Leon Moulder's Trading History
| ZLABZai Lab | Jun 22, 2026 | Director | Uninformative Buy | ― | $2.10M | |
| ZBIOZenas BioPharma, Inc. | May 18, 2026 | CEO, Director | Informative Buy | 1.01M | $65.47M | |
| DNTHDianthus Therapeutics | Jan 24, 2024 | Director | Uninformative Buy | 2.00M | $118.36M | |
| TRVNTrevena | Feb 04, 2019 | Director | Informative Buy | 102.00K | $1.65K | |
| TSROTesaro | Jan 22, 2019 | ― | Uninformative Sell | 77.97M | $0.00 | |
| CBSTCubist Pharma | Jan 21, 2015 | ― | Uninformative Sell | 1.13M | ― |
You May Also Like
Leon Moulder insider profile FAQ
What is the percentage of profitable transactions made by Leon Moulder?
The percentage of profitable transactions made by Leon Moulder is 73%.
What is the average return per transaction made by Leon Moulder?
The average return per transaction made by Leon Moulder is 81.60%.
What stocks does Leon Moulder hold?
Leon Moulder holds: ZLAB, TSRO, DNTH, ZBIO, TRVN, CBST stocks.
What was Leon Moulder's most profitable transaction?
Leon Moulder’s most profitable transaction was an Informative Buy of ZBIO stock on December 4, 2024. The return on the trade was 287.20%.
What is Leon Moulder's role in Zai Lab?
Leon Moulder's role in Zai Lab is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.